MELBOURNE, Australia, May 4, 2005 /PRNewswire-FirstCall via COMTEX/ -- Prana
Biotechnology Limited (Nasdaq: PRAN, ASX: PBT), today announced that its
founding scientist, Professor Ashley Bush of Harvard Medical School, will
present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference
at the InterContinental Hotel in Paris on Thursday, May 5, 2005, at 12:40 PM
CET.
Professor Bush's presentation will contain a scientific review of the MPAC
(Metal-Protein Attenuating Compounds) theory. A live web cast and replay of the
presentation will be available on the Prana Biotechnology web site:
www.pranabio.com.
To arrange a one-on-one meeting with Professor Bush during the conference,
please contact Kathy Price at The Anne McBride Company, tel. 212-983-1702, ext
212, or kprice@annemcbride.com.
The founding scientists', Professors Rudolph Tanzi and Ashley Bush, theories
concerning the interaction between metals and the protein beta-amyloid in the
brain are the basis of Prana's treatments for Alzheimer's and other
neurodegenerative diseases.
About Prana Biotechnology Limited
Prana Biotechnology was established to commercialize research into Alzheimer's
disease and other major age-related degenerative disorders. The company was
incorporated in 1997 and listed on the Australian Stock Exchange in March 2000
and listed on NASDAQ in September 2002. Researchers at prominent international
institutions including the University of Melbourne and Massachusetts General
Hospital, a teaching hospital of Harvard Medical School, discovered Prana's
technology.
For further information, please visit our web site at
www.pranabio.com.
Contacts:
Investor Relations Media Relations
Kathy Price Ivette Almeida
T: 212-983-1702 ext. 212 T: 212-983-1702 ext. 209
E: kprice@annemcbride.com E: ivette.almeida@annemcbride.com
SOURCE Prana Biotechnology Limited
CONTACT: Investor Relations